Literature DB >> 6870067

Sweat chloride concentration in adults with pulmonary diseases.

P B Davis, S Del Rio, J A Muntz, L Dieckman.   

Abstract

In order to determine whether a high proportion of adults with pulmonary diseases have sweat chloride concentrations in the range usually considered diagnostic for cystic fibrosis (greater than 60 mEg/L), we performed the standard diagnostic "sweat test" of Gibson and Cooke prospectively on 187 subjects 18 to 85 yr of age who did not have cystic fibrosis (166 of them had some pulmonary or allergic disorder, and 21 were healthy). In this group, 99% had sweat chloride concentration less than 70 mEq/L, and 96%, less than 60 mEq/L. Those taking steroids had sweat chloride concentration slightly but significantly lower than those who did not take steroids, probably because of the mineralocorticoid effect. Six patients had pancreatitis, and 2 of those had sweat chloride concentration greater than 60 mEq/L, a distribution of values significantly different (p less than 0.005) from the rest of the population. Our results suggest that a very small proportion of adults with pulmonary diseases have sweat chloride concentrations in the range usually considered diagnostic for cystic fibrosis, and that the sweat test is a good discriminant for cystic fibrosis even in the adult age group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870067     DOI: 10.1164/arrd.1983.128.1.34

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  The limitations of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systematic review.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2007-05

2.  Sweat osmolality in Down's syndrome and cystic fibrosis in an Indian population.

Authors:  H Geetha; K T Shetty
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

3.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.

Authors:  C S Chu; B C Trapnell; S M Curristin; G R Cutting; R G Crystal
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

4.  Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype.

Authors:  V Dumur; R Gervais; J M Rigot; E Delomel-Vinner; B Decaestecker; J J Lafitte; P Roussel
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

Review 5.  Relapsing pancreatitis as initial manifestation of cystic fibrosis in a young man without pulmonary disease.

Authors:  V Gross; J Schoelmerich; K Denzel; W Gerok
Journal:  Int J Pancreatol       Date:  1989-03

6.  Infusion of freshly isolated autologous bone marrow derived mononuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model.

Authors:  Mauricio Rojas; Richard E Parker; Natalie Thorn; Claudia Corredor; Smita S Iyer; Marta Bueno; Lyle Mroz; Nayra Cardenes; Ana L Mora; Arlene A Stecenko; Kenneth L Brigham
Journal:  Stem Cell Res Ther       Date:  2013-03-04       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.